← Eichor
Condition: Sarcoma Kaposi Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Sarcoma Kaposi

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Sequential Infusion of CD146-Targeted and HER2-Targeted CAR T Cells in Patients With Advanced Sarcomas
Phase 1/Phase 2 · 1 location(s) · Essen Biotech · NCT07066982The Effects of Sirolimus in Patients With Dilated Cardiomyopathy Infected With Kaposi Sarcoma-associated Virus
Phase 4 · 1 location(s) · Tongji Hospital · NCT06236022Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia.
NA · 1 location(s) · Alpha Tau Medical LTD. · NCT03889899Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
Phase N/A · 8 location(s) · AIDS Malignancy Consortium · NCT05663502Natural History of KSHV-Associated Multicentric Castleman s Disease
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT04968288Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cance
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT00006518A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
Phase 1 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT05859074Trial of Ixazomib for Kaposi Sarcoma
Phase 2 · 11 location(s) · AIDS Malignancy Consortium · NCT04305691Molecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune Disorders
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT03300830Natural History Study of Kaposi Sarcoma
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT06375122Precision Imaging to Evaluate Kaposi Sarcoma (PRIME-KS): A Device Feasibility Trial
Phase N/A · 1 location(s) · Washington University School of Medicine · NCT06751355Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia
NA · 1 location(s) · Alpha Tau Medical LTD. · NCT04534127PDS01ADC Monotherapy and in Combination With M7824 in Advanced Kaposi Sarcoma
Phase 1/Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT04303117Recombinant Glycosylated Human Interleukin-7 (CYT107) for the Treatment of Kaposi Sarcoma in Participants With HIV and I
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT07308886Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma
Phase 1/Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT04941274Agnostic Therapy in Rare Solid Tumors
Phase 2 · 8 location(s) · Instituto do Cancer do Estado de São Paulo · NCT06638931Phase II Study of Pacritinib in Kaposi Sarcoma Herpesvirus (KSHV)-Associated Multicentric Castleman Disease and KSHV-Ass
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT06052618Propranolol for the Treatment of Kaposi Sarcoma in Adults
Phase 2 · 1 location(s) · Washington University School of Medicine · NCT06445166AYAHIV Role-based Responsibilities for Oncology-focused Workforce (ARROW)
NA · 1 location(s) · Implenomics · NCT06004011Pomalidomide and Nivolumab in People With Virus-Associated Malignancies With or Without HIV
Phase 1 · 1 location(s) · National Cancer Institute (NCI) · NCT04902443Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman Diseas
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT05907759Precision Imaging to Evaluate Kaposi Sarcoma
NA · 2 location(s) · Washington University School of Medicine · NCT06898203Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT01419561Study of SGR-1505 in Mature B-Cell Neoplasms
Phase 1 · 36 location(s) · Schrödinger, Inc. · NCT05544019
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.